Newly discovered molecules that could prove to be anti-cancer agents.
Plant-derived compounds that could give us new ammunition against deadly drug-resistant bacteria such as MRSA.
Nanoparticles that might one day help doctors focus cancer drugs more precisely on tumors.
New drug candidates to minimize damage to the brain after a stroke.
That’s a small sample of the research that UNCG’s Medicinal Chemistry Collaborative– MC2 – is carrying out.
And there’s certainly more where that came from. That’s what happens when you combine a couple dozen chemists, biochemists, biologists and other scientists, plus their labs, students and millions of dollars in research grants, together in a single center.
Originally published January 3, 2018.